Search

everythinglearnresearchcommunity

for

Search:↓

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Microarray analysis helps find hidden chromosomal changes in patients with intellectual disabilities and birth defects.

Vitamin C derivative reduces hair loss-related protein in cells.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

ABCG2 protein marks stem-like skin cells in human epidermis.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

JAK inhibitors may reduce depression in people with alopecia areata.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.